Will there be at least 2100 measles cases in the U.S. by April 30, 2026?
Will there be at least 2100 measles cases in the U.S. by April 30, 2026? Odds: 0.7% YES on Polymarket. See live prices and trade this market.
Measles Cases Prediction Market Analysis
Current Odds
| Platform | Yes | No | Volume | Trade |
|---|---|---|---|---|
| Polymarket | 0.7% | 99.4% | $10K | Trade on Polymarket |
Market Analysis
The near-zero odds suggest market participants view a major measles outbreak exceeding 2,100 cases by April 2026 as extremely unlikely, despite recent upticks in anti-vaccine sentiment and declining immunization rates across certain U.S. demographics. This market essentially prices in the baseline scenario where current vaccination coverage—around 93% nationally for MMR—holds steady and doesn’t collapse further, a reasonable assumption given institutional resistance to dramatic shifts in public health infrastructure within 16 months. The low probability reflects both the high bar of 2,100+ cases (we’ve only exceeded this threshold three times since 2000: 2011, 2014-2015, and 2019) and confidence that another sustained outbreak on that scale would require either a coordinated anti-vaccine movement that penetrates beyond current hotspots or a significant policy reversal at the federal or state level.
The bull case hinges on measles’ explosive contagion profile and shrinking pockets of unvaccinated populations in certain states. If anti-vaccine activism accelerates following the 2024 election and gains legislative backing under a vaccine-skeptical administration (a real political risk through April 2026), exemption rates could spike in key states like Idaho, Mississippi, or Wyoming. Minnesota’s 2019 outbreak—which hit 79 cases—showed how rapidly measles can spread through unvaccinated communities; scaling that across multiple regions simultaneously is mechanically possible. Additionally, seasonal winter surges could compound case counts if January-February 2026 sees travel-related introductions coincide with lower population immunity. The bear case is stronger: measles requires 95% herd immunity to contain, and we’re currently above 90% nationally, creating a significant buffer. Most U.S. measles cases (roughly 70% historically) are imported rather than community-transmitted, meaning domestic spread remains constrained. Even amid the 2022-2024 period of rising anti-vaccine rhetoric, measles cases remained in the low hundreds annually. Reversing decades of institutional MMR infrastructure and epidemiological momentum in under 16 months is a heavy lift.
Watch for three specific catalysts: congressional or state legislative action on vaccine exemptions between now and summer 2025 (any major rollback of medical exemptions-only rules would shift odds meaningfully), disease surveillance data releases from the CDC each quarter showing whether unvaccinated clusters are expanding, and any measles importations tied to international travel during winter 2025-2026. If RFK Jr.’s HHS influence produces concrete policy shifts weakening vaccine requirements at the federal level (targeted deadlines: post-confirmation through mid-2025), odds should drift higher. Conversely, if 2025 ends with measles remaining <500 annual cases and no legislative action materializing, the 0.7% floor will likely hold or compress further, as it becomes increasingly difficult to geometrically accelerate cases in the final four months.
Related Markets
- Will Ron DeSantis win the 2028 US Presidential Election? — 2% YES
- Will the Philadelphia Phillies win the 2026 World Series? — 3% YES
- Will Amanda Anisimova be the 2026 Women’s Wimbledon Winner? — 8% YES
Frequently Asked Questions
How many annual measles cases would we need to see by late 2025 for the 2,100 threshold to look achievable?
Roughly 1,000+ cases in the 12 months preceding April 2026 would suggest momentum toward this target; the U.S. hasn’t hit 1,000 annually since 2011, so this would represent a historic spike requiring simultaneous outbreaks across multiple regions.
If a major state like California or Texas significantly rolled back vaccine requirements, would that automatically push odds higher?
Not automatically—it would depend on baseline immunity levels in that state and whether medical exemptions were still enforced; a
Learn More
Key Dates
- Market Expiry: April 30, 2026 (7 days from now)
- Final Trading: Market approaches settlement — expect reduced liquidity